Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
23andMe and Nightingale Health to Collaborate on Pilot for Blood Biomarker Panel
Saturday, June 29, 2024andMe Holding Co and Nightingale Health Plc have announced a strategic collaboration to pilot Nightingale Healths clinicallyvalidated blood metabolomics panel with a group of andMe members
Pfizer and BioNTech Receive Positive CHMP Recommendation for EU Approval of Omicron JN.1-adapted COVID-19 Vaccine
Friday, June 28, 2024Pfizer Inc and BioNTech SE have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended marketing authorization
Meitheal Pharmaceuticals Secures Exclusive U.S. Licensing Deal for Humira® Biosimilar YUSIMRY® to Enhance Biologics Portfolio
Friday, June 28, 2024Meitheal Pharmaceuticals Inc headquartered in Chicago has secured exclusive commercial rights in the US for YUSIMRY a biosimilar of Humira through a licensing and supply agreement
Agile Therapeutics, Inc. and Insud Pharma, S.L. Sign Definitive Merger Agreement
Thursday, June 27, 2024Agile Therapeutics Inc a womens healthcare company announced a definitive merger agreement with Insud Pharma SL a global pharmaceutical group based in Spain Through its US subsidiary Exeltis Project Inc Insud will acquire Agile for per share in cash...
Simcere and Zaiming Announce NMPA Approval for Cetuximab Beta in China
Thursday, June 27, 2024Simcere Zaiming an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group has announced that Enlituo an advanced antiepidermal growth factor receptor antibody drug developed in collaboration with Mabpharm Limited has recently be...
Epcoritamab (EPKINLY®) FDA Approved for Patients with Relapsed or Refractory Follicular Lymphoma (FL)
Thursday, June 27, 2024Genmab AS has received approval from the US Food and Drug Administration for EPKINLY to treat adults with relapsed or refractory follicular lymphoma after two or more prior systemic therapies
Junshi Biosciences Receives Approval for Toripalimab as a First-Line Therapy for Advanced Triple-Negative Breast Cancer
Wednesday, June 26, 2024Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Lilly and OpenAI Collaborate on Developing New Treatments for Drug-Resistant Bacteria
Wednesday, June 26, 2024Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Porton Advanced Launches MaxCyte ExPERT GTx Flow Electroporation System to Enhance Cell and Gene Therapy Offerings
Wednesday, June 26, 2024Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
Biond Biologics Begins Phase 1 Clinical Trial, Administers First Dose of BND-35
Tuesday, June 25, 2024Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient...
